BSE filing, BSE: 544165. Summary written from the filing by ALFA Finder's alert engine.
Shivam Chemicals Ltd: key numbers
- Share price
- ₹143.00
- Market cap
- ₹242.9 Cr
- Revenue (annual)
- ₹284.2 Cr
- Net profit (annual)
- ₹6.19 Cr
- P/E (TTM)
- 39.2×Sector 26.2×
- Promoter holding
- 73.00%+0.00% QoQ
- FII holding
- 1.48%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Shivam Chemicals Ltd
All →Shivam Chemicals Board Meeting Date
Shivam Chemicals Limited intimated a board meeting on 03 Nov 2026 to consider unaudited standalone and consolidated results for the half year ended 30 September 2026. The trading window stays closed for 48 hours after the meeting or results release.
Shivam Chemicals Other Announcement
Shivam Chemicals Ltd has filed its quarterly shareholding pattern statement under Regulation 31(1)(b) of SEBI LODR Regulations. This is a routine periodic regulatory compliance filing.
Shivam Chemicals Production Started
Shivam Chemicals has commenced production of Feed-Grade Dicalcium Phosphate at its subsidiary's facility in Dahej, Gujarat. This expansion integrates in-house manufacturing into their existing distribution business.
Shivam Chemicals Annual General Meeting
Shivam Chemicals Ltd held its 16th Annual General Meeting on 21st September, 2026, where shareholders considered the adoption of financial statements and the re-appointment of a director.
Shivam Chemicals Business Update
Shivam Chemicals has resumed exports of renewable energy feedstock for the biofuel industry to the United States. This restart reflects renewed demand and operational stability.
Shivam Chemicals Annual General Meeting
Shivam Chemicals Limited has issued the notice for its 16th Annual General Meeting to be held on September 21, 2026. The meeting will address ordinary business items.
Other other announcement announcements
All →Setubandhan Infrastructure Other Announcement
RP informs exchanges that Setubandhan Infrastructure cannot file quarterly compliance documents due to depository fee non-payment. The company remains under CIRP with a pending NCLAT appeal.
Man Infraconstruction Other Announcement
Man Infraconstruction filed a Reg 32 quarterly statement confirming no deviation in use of preferential-warrant proceeds. No deviation or variation arose for the quarter ended September 30, 2026.
Black Buck Other Announcement
BlackBuck's ICRA monitoring agency report for Q1 FY27 confirms IPO proceeds utilization remains in line with stated objects. No deviation was observed in the quarter.
Raama Finance Other Announcement
Raama Finance appointed M/s. Kumar Gaurav & Co. as statutory auditor for three months effective October 29, 2026. The routine appointment carries no financial impact.
Teja Engineering Industries Other Announcement
Teja Engineering Industries filed a non-applicability certificate for Reg 27(2) Corporate Governance for Q1 FY27. As an NSE Emerge-listed SME, the company is exempt from this periodic disclosure.
Prism Medico and Pharmacy Other Announcement
Prism Medico and Pharmacy intimated BSE and MSEI that its corporate website is updated and functional per Regulation 46. This is a routine compliance undertaking with no financial impact.